{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:06:43Z","timestamp":1793509603482,"version":"4.5.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,19]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Allogeneic hematopoietic stem cell transplantation (HSCT) is the only established curative option for Fanconi anemia (FA)\u2013associated bone marrow failure (BMF)\/aplastic anemia (AA) and acute myeloid leukemia (AML)\/myelodysplastic syndrome (MDS). We performed a retrospective multicenter study on 813 children with FA undergoing first HSCT between 2010 and 2018. Median duration of follow-up was 3.7 years. Median age at transplant was 8.8 years (IQR, 6.5-18.1). Five-year overall survival (OS), event-free survival (EFS), and graft-versus-host disease (GVHD)-free, relapse-free survival (GRFS) were 83% (95% confidence interval [CI], 80-86), 78% (95% CI, 75-81), and 70% (95% CI, 67-74), respectively. OS was comparable between matched family donor (MFD; n\u00a0=\u00a0441, 88%) and matched unrelated donor (MUD; n\u00a0=\u00a0162, 86%) and was superior to that of mismatched family donor (MMFD) or mismatched unrelated donor (MMUD; n\u00a0=\u00a0144, 72%) and haploidentical donor (HID; n\u00a0=\u00a066, 70%; P\u00a0&amp;lt; .001). In multivariable analysis, a transplant indication of AML\/MDS (vs AA\/BMF), use of MMFD\/MMUD and HID (vs MFD), and fludarabine-cyclophosphamide (FluCy) plus other conditioning (vs FluCy) independently predicted inferior OS, whereas alemtuzumab vs antithymocyte globulin was associated with better OS. Age \u226510 years was associated with worse EFS and GRFS. Cumulative incidences (CINs) of primary and secondary graft failure were 2% and 3% respectively. CINs of grade 3 to 4 acute GVHD and chronic GVHD were 12% and 8% respectively. The 5-year CIN of secondary malignancy was 2%. These data suggest that HSCT should be offered to patients with FA with AA\/BMF at a younger age in the presence of a well-matched donor.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2023022751","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T17:07:22Z","timestamp":1720199242000},"page":"1329-1342","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":34,"title":["Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia"],"prefix":"10.1182","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-029X","authenticated-orcid":false,"given":"Su Han","family":"Lum","sequence":"first","affiliation":[{"name":"1Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"},{"name":"2Great North Children's Hospital, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk-Jan","family":"Eikema","sequence":"additional","affiliation":[{"name":"3EBMT Statistical Unit, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5990-2211","authenticated-orcid":false,"given":"Brian","family":"Piepenbroek","sequence":"additional","affiliation":[{"name":"4EBMT Leiden Study Unit, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Wynn","sequence":"additional","affiliation":[{"name":"5Royal Manchester Children's Hospital, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujith","family":"Samarasinghe","sequence":"additional","affiliation":[{"name":"6Great Ormond Street Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Dalissier","sequence":"additional","affiliation":[{"name":"7EBMT Paris Study Unit, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-5799","authenticated-orcid":false,"given":"Krysztof","family":"Kalwak","sequence":"additional","affiliation":[{"name":"8Department of Pediatric Hematology, Oncology, and BMT, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-1302","authenticated-orcid":false,"given":"Mouhab","family":"Ayas","sequence":"additional","affiliation":[{"name":"9King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose-Marie","family":"Hamladji","sequence":"additional","affiliation":[{"name":"10Centre Pierre et Marie Curie, Algiers, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif","family":"Yesilipek","sequence":"additional","affiliation":[{"name":"11Medical Park Antalya Hospital, Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Hugues","family":"Dalle","sequence":"additional","affiliation":[{"name":"12H\u00f4pital Robert Debre, GHU Assistance Publique\u2013H\u00f4pitaux de Paris Nord, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Uckan-Cetinkaya","sequence":"additional","affiliation":[{"name":"13Hacettepe University Children's Hospital, BMT Unit, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bierings","sequence":"additional","affiliation":[{"name":"14Princess Maxima Center\/University Hospital for Children, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphan","family":"Kupesiz","sequence":"additional","affiliation":[{"name":"15Akdeniz University Medical School, Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-9138","authenticated-orcid":false,"given":"Khalid","family":"Halahleh","sequence":"additional","affiliation":[{"name":"16King Hussein Cancer Centre, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-1444","authenticated-orcid":false,"given":"Elena","family":"Skorobogatova","sequence":"additional","affiliation":[{"name":"17Russian Children's Research Hospital, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9268-8858","authenticated-orcid":false,"given":"G\u00fcly\u00fcz","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"18Ac\u0131badem Sa\u011flik Hizmetleri ve Ticaret AS, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-501X","authenticated-orcid":false,"given":"Maura","family":"Faraci","sequence":"additional","affiliation":[{"name":"19Department of Hematology-Oncology, Hematology Unit, G. Gaslini IRCCS Institute, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Renard","sequence":"additional","affiliation":[{"name":"20Institut d'Hematologie et d'Oncologie Pediatrique, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Evans","sequence":"additional","affiliation":[{"name":"21Children's Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Corbacioglu","sequence":"additional","affiliation":[{"name":"22Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"23IRCCS Ospedale Pediatrico Bambino Ges\u00f9, Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dufour","sequence":"additional","affiliation":[{"name":"19Department of Hematology-Oncology, Hematology Unit, G. Gaslini IRCCS Institute, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-5109","authenticated-orcid":false,"given":"Antonio","family":"Risitano","sequence":"additional","affiliation":[{"name":"24AORN S. Giuseppe Moscati, Avellino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Peffault de Latour","sequence":"additional","affiliation":[{"name":"25BMT Unit, French Reference Center for Aplastic Anemia and PNH, H\u00f4pital Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2024091915210474600_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/35076590","article-title":"The emerging genetic and molecular basis of Fanconi anaemia","volume":"2","author":"Joenje","year":"2001","journal-title":"Nat Rev Genet"},{"issue":"10","key":"2024091915210474600_bib2","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3390\/genes12101520","article-title":"Fanconi anaemia, childhood cancer and the BRCA genes","volume":"12","author":"Woodward","year":"2021","journal-title":"Genes (Basel)"},{"issue":"1","key":"2024091915210474600_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cge.12517","article-title":"Fanconi anaemia: genetics, molecular biology, and cancer-implications for clinical management in children and adults","volume":"88","author":"Schneider","year":"2015","journal-title":"Clin Genet"},{"issue":"4","key":"2024091915210474600_bib4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A\u00a020-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"issue":"1","key":"2024091915210474600_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjh.15006","article-title":"Transplant results in adults with Fanconi anaemia","volume":"180","author":"Bierings","year":"2018","journal-title":"Br J Haematol"},{"issue":"26","key":"2024091915210474600_bib6","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2013-01-479733","article-title":"Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience","volume":"122","author":"Peffault de Latour","year":"2013","journal-title":"Blood"},{"issue":"24","key":"2024091915210474600_bib7","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood-2015-02-626002","article-title":"Alternative donor hematopoietic cell transplantation for Fanconi anemia","volume":"125","author":"MacMillan","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2024091915210474600_bib8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2007.05.015","article-title":"Results\u00a0of unrelated cord blood transplant in\u00a0fanconi anemia patients: risk factor analysis\u00a0for engraftment and survival","volume":"13","author":"Gluckman","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2024091915210474600_bib9","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3324\/haematol.11436","article-title":"The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian Pediatric Group","volume":"92","author":"Locatelli","year":"2007","journal-title":"Haematologica"},{"issue":"4","key":"2024091915210474600_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.1980.tb07178.x","article-title":"Bone marrow transplantation in Fanconi anaemia","volume":"45","author":"Gluckman","year":"1980","journal-title":"Br J Haematol"},{"issue":"4","key":"2024091915210474600_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2141.1980.tb07179.x","article-title":"In\u00a0vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients","volume":"45","author":"Berger","year":"1980","journal-title":"Br J Haematol"},{"issue":"1","key":"2024091915210474600_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-4608(83)90021-3","article-title":"Effect of procarbazine and cyclophosphamide on chromosome breakage in Fanconi anemia cells: relevance to bone marrow transplantation","volume":"9","author":"Auerbach","year":"1983","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"2024091915210474600_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2141.1983.tb02117.x","article-title":"Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation","volume":"54","author":"Gluckman","year":"1983","journal-title":"Br J Haematol"},{"issue":"7","key":"2024091915210474600_bib14","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood.V86.7.2856.2856","article-title":"Bone marrow transplantation for Fanconi anemia","volume":"86","author":"Gluckman","year":"1995","journal-title":"Blood"},{"issue":"2","key":"2024091915210474600_bib15","first-page":"422","article-title":"Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation","volume":"95","author":"Guardiola","year":"2000","journal-title":"Blood"},{"issue":"5","key":"2024091915210474600_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/pbc.20538","article-title":"Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation","volume":"46","author":"Tan","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"2024091915210474600_bib17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bbmt.2007.08.004","article-title":"HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg\/kg of cyclophosphamide","volume":"13","author":"Bonfim","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2024091915210474600_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbmt.2008.06.020","article-title":"HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens","volume":"14","author":"Pasquini","year":"2008","journal-title":"Biol Blood\u00a0Marrow Transplant"},{"issue":"4","key":"2024091915210474600_bib19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/bjh.17418","article-title":"Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience","volume":"193","author":"Bernard","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"2024091915210474600_bib20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/bloodadvances.2020003707","article-title":"HLA-haploidentical TCRalphabeta+\/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia","volume":"5","author":"Strocchio","year":"2021","journal-title":"Blood Adv"},{"issue":"2","key":"2024091915210474600_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbmt.2016.11.006","article-title":"Haploidentical bone marrow transplantation with post-transplant cyclophosphamide for children and adolescents with Fanconi anemia","volume":"23","author":"Bonfim","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2024091915210474600_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bjh.18408","article-title":"Unmanipulated haploidentical haematopoietic cell transplantation with radiation-free conditioning in Fanconi anaemia: a retrospective analysis from the Chinese Blood and Marrow Transplantation Registry Group","volume":"199","author":"Xu","year":"2022","journal-title":"Br J Haematol"},{"issue":"20","key":"2024091915210474600_bib40","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1097\/CM9.0000000000001471","article-title":"Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia","volume":"134","author":"Wang","year":"2021","journal-title":"Chin Med J"},{"issue":"24","key":"2024091915210474600_bib23","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"How I treat MDS and AML in Fanconi anemia","volume":"127","author":"Peffault de Latour","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2024091915210474600_bib24","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bbmt.2016.05.021","article-title":"Addition of high-dose cytarabine to fludarabine-based conditioning for hematopoietic stem cell transplantation for treating Fanconi anemia patients with advanced myeloid malignancy: a single-center experience and literature review","volume":"22","author":"Aoki","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2024091915210474600_bib25","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.3324\/haematol.2013.098954","article-title":"Sequential treatment for allogeneic hematopoietic stem cell transplantation in\u00a0Fanconi anemia with acute myeloid leukemia","volume":"99","author":"Talbot","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"2024091915210474600_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bmt.2014.283","article-title":"Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML","volume":"50","author":"Beier","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2024091915210474600_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41409-020-0994-2","article-title":"FLAG-sequential regimen followed by bone marrow transplantation for\u00a0myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study","volume":"56","author":"Debureaux","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2024091915210474600_bib28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ajh.25810","article-title":"Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: a\u00a0retrospective analysis on behalf of EBMT\u00a0group","volume":"95","author":"Giardino","year":"2020","journal-title":"Am J Hematol"},{"issue":"4","key":"2024091915210474600_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.12234","article-title":"Cancer risks in Fanconi anemia: findings from the German Fanconi anemia registry","volume":"93","author":"Rosenberg","year":"2008","journal-title":"Haematologica"},{"issue":"1","key":"2024091915210474600_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V87.1.386.386","article-title":"Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients","volume":"87","author":"Deeg","year":"1996","journal-title":"Blood"},{"issue":"2","key":"2024091915210474600_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12094-021-02693-8","article-title":"Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy","volume":"24","author":"Murillo-Sanjuan","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"2024091915210474600_bib32","volume-title":"Anemia Clinical Care Guidelines","year":"2020","edition":"5th Ed."},{"issue":"1","key":"2024091915210474600_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/08880018.2015.1129567","article-title":"Androgen therapy in Fanconi anemia: a retrospective analysis of 30 years in Germany","volume":"33","author":"Paustian","year":"2016","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"2024091915210474600_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bjh.12634","article-title":"Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia","volume":"164","author":"Mitchell","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2024091915210474600_bib35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/hematology.2022000393","article-title":"Modern management of Fanconi anemia","volume":"2022","author":"Dufour","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"2024091915210474600_bib36","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/bloodadvances.2020004072","article-title":"T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity","volume":"6","author":"Lum","year":"2022","journal-title":"Blood Adv"},{"issue":"5","key":"2024091915210474600_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2024091915210474600_bib38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2014.01.015","article-title":"HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia","volume":"20","author":"Zecca","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2024091915210474600_bib39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3109\/08880018.2012.708708","article-title":"Cyclophosphamide-based in\u00a0vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia","volume":"29","author":"Thakar","year":"2012","journal-title":"Pediatr Hematol Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/12\/1329\/2242661\/blood_bld-2023-022751-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/12\/1329\/2242661\/blood_bld-2023-022751-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:37:41Z","timestamp":1726763861000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/12\/1329\/516854\/Outcomes-of-hematopoietic-stem-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,9,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023022751","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}